Literature DB >> 20116265

Carboxylated calixarenes bind strongly to CD69 and protect CD69(+) killer cells from suicidal cell death induced by tumor cell surface ligands.

Karel Bezouska1, Renata Snajdrová, Karel Krenek, Markéta Vancurová, Alan Kádek, David Adámek, Pavel Lhoták, Daniel Kavan, Katerina Hofbauerová, Petr Man, Pavla Bojarová, Vladimír Kren.   

Abstract

We have recently identified a new class of high affinity ligands for CD69 leukocyte membrane receptor, carboxylated calixarenes. Of the three compounds investigated here, thiacalix[4]arene had the highest affinity for CD69 in direct binding assays, and proved to be the most specific inhibitor of CD69 identified so far in receptor precipitation and cellular activation experiments. Carboxylated calixarenes also proved effective at protection of CD69(high) lymphocytes from apoptosis triggered by a multivalent ligand or antibody. Thus, carboxylated calixarenes set a new paradigm for noncarbohydrate ligands for CD69 making them attractive for protection of killer cells in combined animal tumor therapies. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20116265     DOI: 10.1016/j.bmc.2010.01.015

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Antitumor activity of N-acetyl-D-glucosamine-substituted glycoconjugates and combined therapy with keyhole limpet hemocyanin in B16F10 mouse melanoma model.

Authors:  K Hulíková; V Grobárová; R Křivohlavá; A Fišerová
Journal:  Folia Microbiol (Praha)       Date:  2010-10-13       Impact factor: 2.099

2.  Re-evaluation of binding properties of recombinant lymphocyte receptors NKR-P1A and CD69 to chemically synthesized glycans and peptides.

Authors:  Daniel Rozbeský; Jana Krejzová; Karel Křenek; Jan Prchal; Richard Hrabal; Milan Kožíšek; Lenka Weignerová; Michele Fiore; Pascal Dumy; Vladimír Křen; Olivier Renaudet
Journal:  Int J Mol Sci       Date:  2014-01-17       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.